1. Molecular thrombophilic profile in Mexican patients with idiopathic recurrent pregnancy loss
- Author
-
C I Juárez-Vázquez, A. R. Jaloma-Cruz, J J López-Jiménez, C A Fuentes-Chávez, Á Porras-Dorantes, Irving J. Lara-Navarro, and José Elías García-Ortiz
- Subjects
Abortion, Habitual ,medicine.medical_specialty ,030204 cardiovascular system & hematology ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,Internal medicine ,Genetic model ,Genetics ,medicine ,Humans ,Thrombophilia ,Mexico ,Molecular Biology ,Demography ,030219 obstetrics & reproductive medicine ,biology ,business.industry ,Fibrinolysis ,Case-control study ,General Medicine ,Odds ratio ,medicine.disease ,Confidence interval ,Case-Control Studies ,Methylenetetrahydrofolate reductase ,biology.protein ,Etiology ,Gestation ,Female ,business - Abstract
Idiopathic recurrent pregnancy loss (IRPL) is defined by three or more consecutive miscarriages occurring before the twentieth week of gestation as a result of unidentified etiological factors. The results of previous studies have indicated that prothrombotic factors play a pathogenic role in early and late pregnancy. This study aimed to identify inherited prothrombotic and hypofibrinolytic risk factors in Mexican-Mestizo patients with IRPL. Fifty-six women with IRPL and 50 control women with at least two full-term pregnancies and no history of RPL were included in this case-control study. Four prothrombotic (F5 G1691A, F2 G20210A, MTHFR C677T-A1298C) and one hypofibrinolytic (PAI1 4G/5G) restricted fragment length polymorphisms were subjected to molecular analysis. In the case of hypofibrinolytic ACE Ins/Del (I/D), identification was performed by direct PCR. The independent risk correlated with the presence of polymorphisms in IRPL patients was estimated using odds ratio (OR) with a 95% confidence interval (CI). MTHFR 677TT was the most frequent prothrombotic factor in the IRPL group (23%), followed by the compound-heterozygous C677T-A1298C (16%) and heterozygous F2 20210GA (3.6%). The heterozygous ACE I/D (62%) was the main hypofibrinolytic risk factor of IRPL, followed by the homozygote PAI1 4G/4G (18%). The ACE I/D polymorphism was the only significantly different factor among the cases and controls. The dominant genetic model D/D+I/D vs I/I showed an OR (95%CI) of 2.89 (1.22-6.89) and P = 0.019 in Mexican-Mestizo women. The results of this study support an association between the ACE I/D polymorphism and IRPL risk in a Mexican population.
- Published
- 2016
- Full Text
- View/download PDF